JOIN THE
FIGHT FOR SIGHT

We are so close to life changing breakthroughs.

Join the fight by discovering more below or donate any amount now to be part of the breakthroughs putting an end to sight loss.

Be part of the next breakthrough.

We are at the crucial point in our fight against sight loss. With your support we can continue to improve lives today and transform them tomorrow with crucial research that is making breakthroughs in treatments.

Hear about Jonathan's, Joe's, Jackson's and Neil's fights against sight loss below.

Sign up for e-news updates
play-button

FIGHT FOR

SIGHT

After an unexpected diagnosis of age-related macular degeneration, Jonathan found the attendant threat of a loss of independence understandably alarming. Our research is helping him fight back.

Age-related macular degeneration is often caused by an inflammation of eye cells and is the leading cause of blindness in the UK.

DR HILL

AND HER FIGHT FOR SIGHT

Dr Hill is part of the research team bringing hope and independence to people lives by developing eyedrops to replace multiple injections for the treatment of macular degeneration.

play-button

FIGHT FOR

SIGHT

Jackson was diagnosed with an inherited eye disorder called Leber congenital amaurosis (LCA), at just two and a half months old. It has already resulted in the loss of his central vision, but our research is striving for a cure.

LCA is an inherited condition that can cause sight loss in childhood because photoreceptor cells at the back of the eye stop working properly.

PROFESSOR CHEETHAM

AND HIS FIGHT FOR SIGHT

Professor Cheetham and his team are leading research into this and many other sight conditions aided by their ability to grow “mini-retinas” in their lab to keep fighting back against sight loss.

play-button

FIGHT FOR

SIGHT

Sight loss hit Joe hard and by the time he was 16 he was mentally exhausted. But Joe found Fight for Sight and was accepted onto a gene therapy trial that has helped restore some of his sight.

Choroideremia is an inherited condition causing progressive vision loss. It is estimated that it affects between 1 in 50,000 to 100,000 people in the UK.

DR KAPETANOVIC

AND HER FIGHT FOR SIGHT

Dr Kapetanovic works with Prof. Robert Maclaren who ran the gene therapy trial where a harmless virus carried the missing gene into the back of Joe's eye.

play-button

FIGHT FOR

SIGHT

Neil is Director of Research and Innovation at Fight for Sight and has been exploring research into keratoconus to make a meaningful difference to people’s lives in the UK.

Keratoconus is a condition that affects the cornea, the clear front surface of the eye. The cornea becomes thinner and more cone-shaped over time and can be very painful.

DR EBENEZER

AND HIS FIGHT FOR SIGHT

Fight for Sight's funding helped improve the effectiveness of a new treatment called corneal collagen cross-linkage that creates a supportive “scaffold” around the cornea - the only preventative treatment for this condition.

By 2050 there may be more than four million people living in the UK with sight loss.

To combat this Fight for Sight want to turn more great thinking into cures but a lack of current support holds scientific progress back. Progress that can make a real difference to Jonathan, Jackson, Joe and everyone you know who may be affected.

Sign up to our e-newsletter to discover more about the breakthroughs our researchers are making in their fight for sight.

  • There are currently over two million people living with sight loss. This number is projected to increase to 2.7 million by 2030 and to double by 2050.
  • One in five people will live with sight loss in their lifetime. (Source DAE, 2017)
  • 25,000 children currently have eye diseases that cause blindness and serious sight loss. (Source RNIB)
  • Forty percent of people are either affected by significant sight loss or know someone with serious sight loss. (Source: YouGov poll for Fight for Sight, September 2019)
  • 84 percent of Brits say sight is the sense they fear losing the most (YouGov poll for Fight for Sight, September 2019)
  • Only one percent of public grant funding is invested in eye research despite eye conditions making up more than 10 percent of NHS outpatients appointments.

There have been so many breakthroughs, but with your help we can make so many more.